260 related articles for article (PubMed ID: 197724)
1. [Monoaminergic systems of the brain and behavior].
Budantsev AIu; Azarashvili AA; Zharikov SI; Arkhipov VI
Usp Fiziol Nauk; 1977; 8(2):53-74. PubMed ID: 197724
[No Abstract] [Full Text] [Related]
2. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
Fuxe K; Hökfelt T; Olson L; Ungerstedt U
Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
[No Abstract] [Full Text] [Related]
3. Neuroanatomical and neurochemical substrate of pleasure.
Cytawa J; Trojniar W
Acta Physiol Pol; 1980; 31 Suppl 20():85-106. PubMed ID: 6105761
[No Abstract] [Full Text] [Related]
4. Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
Blier P
J Psychopharmacol; 2008 Aug; 22(6):587-9. PubMed ID: 18753271
[No Abstract] [Full Text] [Related]
5. [Significance of the reciprocal relationship of monoaminergic systems of the brain in the pharmacological compensation of 6-hydroxydopamine-induced behavior disorders in animals].
Gromova EA; Semenova TP
Biull Eksp Biol Med; 1989 Jan; 107(1):52-4. PubMed ID: 2521566
[TBL] [Abstract][Full Text] [Related]
6. Chemical transmitter systems in the brain.
Shute CC
Mod Trends Neurol; 1975; 6():183-203. PubMed ID: 607
[No Abstract] [Full Text] [Related]
7. [Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
[No Abstract] [Full Text] [Related]
8. [Neurochemical and neurophysiological organization of phenamine behavioral stereotypy (review of the literature)].
Arushanian EB
Farmakol Toksikol; 1977; 40(2):221-30. PubMed ID: 404184
[No Abstract] [Full Text] [Related]
9. [Monoaminergic inhibitory synapses in the central pathways for the regulation of movements].
Arushanian EB
Usp Fiziol Nauk; 1975; 6(4):100-23. PubMed ID: 174334
[No Abstract] [Full Text] [Related]
10. Effects of damage to the monoamine axonal constituents of the medical forebrain bundle on reactivity to foot shock and ingestive behavior in the rat.
Misantone LJ
Exp Neurol; 1976 Feb; 50(2):448-64. PubMed ID: 1248561
[No Abstract] [Full Text] [Related]
11. [Participation of rat cerebral dopaminergic structures in the process of reproducing conditioned passive avoidance reactions].
Spiridonov VK
Neirofiziologiia; 1976; 8(2):209-11. PubMed ID: 1272468
[No Abstract] [Full Text] [Related]
12. Cellular and molecular aspects of transmitter release: calcium monoamine dynamics.
Radouco-Thomas S
Adv Cytopharmacol; 1971 May; 1():457-75. PubMed ID: 4148192
[No Abstract] [Full Text] [Related]
13. The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Fishman RH; Feigenbaum JJ; Yanai J; Klawans HL
Prog Neurobiol; 1983; 20(1-2):55-88. PubMed ID: 6141594
[No Abstract] [Full Text] [Related]
14. [Biochemical regulation of states of vigilance].
Jouvet M
Int J Neurol; 1975; 10(1-4):141-57, 252-8. PubMed ID: 171233
[No Abstract] [Full Text] [Related]
15. Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
Goldstein M; Anagnoste B; Battista AF; Ogawa M
Pharmacol Ther B; 1976; 2(1):97-103. PubMed ID: 817335
[No Abstract] [Full Text] [Related]
16. Interactions between serotonergic and catecholaminergic systems in the brain.
Kostowski W
Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):15-24. PubMed ID: 1107968
[No Abstract] [Full Text] [Related]
17. [Role of monoaminergic systems in the development of the effect of stimulation of acetylcholinergic brain structures in the cat].
Shugalev NP
Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(1):103-9. PubMed ID: 3984495
[TBL] [Abstract][Full Text] [Related]
18. Two noradrenergic systems in the brain and their interactions with other monoaminergic neurons.
Kostowski W
Pol J Pharmacol Pharm; 1979; 31(4):425-36. PubMed ID: 42889
[TBL] [Abstract][Full Text] [Related]
19. [Relation between the effects of the memory neuromodulator arginine-vasopressin and the levels of activity of the serotonin-, dopamine- and noradrenergic systems of the brain].
Bakharev VD; Starikov VA; Papsuevich OS; Chipens GI
Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):79-87. PubMed ID: 6837162
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine reward pathways: role of self-stimulation, memory consolidation, and schizophrenia.
Stein L
Nebr Symp Motiv; 1975; 22():113-59. PubMed ID: 1688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
